Showing results (321-330 of 1,479) with videos related to
Sort By:
Pageof 148
Human Psychopharmacology|January 16, 2014
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary reportMateus M Bergamaschi, Regina H C Queiroz, Marcos H N Chagas, et al.Human Psychopharmacology|May 4, 2021
Adiponectin predicts poor response to antidepressant drugs in major depressive disorderFrancesco Benedetti, Igor Branchi, Sara Poletti, et al.Human Psychopharmacology|June 5, 2020
Influences on the use of antidepressants in primary care: All England general practice-level analysis of demographic, practice-level and prescriber factorsAdrian H Heald, Mike Stedman, Mark Davies, et al.Human Psychopharmacology|May 26, 2020
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controlsEric M Pearlman, Darren Wilbraham, Ellen B Dennehy, et al.Human Psychopharmacology|August 5, 2021
A phase 1 double-blind, placebo-controlled study of zuranolone (SAGE-217) in a phase advance model of insomnia in healthy adultsAmy Bullock, Handan Gunduz-Bruce, Gary K Zammit, et al.Human Psychopharmacology|January 8, 2026
Comparison of Side Effects Between 3-Monthly and 1-Monthly Paliperidone Palmitate Formulations in Patients With SchizophreniaErkan Kuru, Ilker Ozdemir, Bengu Yucens, et al.Human Psychopharmacology|October 8, 2025
Comprehensive Mitigation of Peripheral and Central Stress Responses by Nx4: Insights From EEG and Heart Rate Variability in Post-Stress Resting StateMarina Krylova, Sarah Alizadeh, Hamidreza Jamalabadi, et al.Human Psychopharmacology|August 9, 2025
Maternal Use of Antidepressants in Pregnancy and the Risk of Postpartum Hemorrhage: An Electronic Health Record-Based Cohort StudyWilliam V Bobo, Launia White, David Hodge, et al.Human Psychopharmacology|August 18, 2025
National Prescribing Trends and Cost Analysis of Antidepressants, Anxiolytics, and Hypnotics in England, 2010-2023Mike Stedman, Mark Davies, John Warner- Levy, et al.Human Psychopharmacology|May 24, 2021
Efficacy of naltrexone in borderline personality disorder, a retrospective analysis in inpatientsCharles Timäus, Miriam Meiser, Jens Wiltfang, et al.Pageof 148